We found that RBCK1 facilitated HCC progression by affecting microvascular invasion, cell migration, and apoptosis, revealing its potential role in tumor immunology and promising value as a prognostic biomarker and therapeutic target for HCC. The gene discussed is RBCK1; the disease is neoplasm.